Our analyses showed a trend for increasing adverse effects with q12h dosage than q24h dosage that is weakly significant without a strong effect of further reducing seizure frequency, suggesting clinicians should begin zonisamide with q24h dosing.
← all excerpts
A retrospective study of the efficacy of zonisamide in controlling seizures in 57 cats.
1
—
—